Verification of brain penetration of the unbound fraction of a novel HER2/EGFR dual kinase inhibitor (TAK-285) by microdialysis in rats.
TAK-285, an investigational, orally active HER2/EGRF inhibitor is in clinical development for potential use in HER2 over-expressing metastatic breast cancer. The objective of the present work was to verify the presence of unbound TAK-285 in the rat brain after oral administration by a microdialysis...
Main Authors: |
Erdő Franciska Gordon J Wu JT Sziraki I |
---|---|
Format: | Article |
Published: |
2012
|
Series: | BRAIN RESEARCH BULLETIN
87 No. 4-5 |
Subjects: | |
doi: | 10.1016/j.brainresbull.2012.01.002 |
mtmt: | 2802853 |
Online Access: | https://publikacio.ppke.hu/2383 |
Similar Items
-
MAP Kinase-Mediated Activation of RSK1 and MK2 Substrate Kinases
by: Sok Péter Dániel, et al.
Published: (2020) -
Az EGFR variánsainak előfordulása és az anti-EGFR terápia kimenetele közötti korreláció vizsgálata fej-nyaki daganatokban
by: Pálházi Balázs
Published: (2014) -
Logo detection and verification with machine learning for document analysis
by: Cajas Ordonez Sebastian Andres
Published: (2022) -
Dual citizenship in the force field of the European Union
by: Gyeney Laura
Published: (2014) -
Dual-pixel CMOS szenzorstruktúra intra-frame mozgásdetekcióhoz
by: Németh Máté
Published: (2019)